You are here
CBE undergrad Ivan Pires receives Student Recognition Award for research
At The Ohio State University Board of Trustees meeting on February 2, CBE undergrad Ivan Susin Pires was one of two students selected to receive the Student Recognition Award.
The meeting was themed on research. During the event, Ivan was introduced and had a few minutes to share some of his experiences with the Board.
Some of those experiences include winning first prize in the Eighth Annual College of Engineering Undergraduate Research Forum for Engineering and Architecture; being selected as one of eight undergrads to represent Ohio State at the 25th Annual SIICUSP Undergraduate Research Meeting in Sao Paulo, Brazil this past October; and winning an Undergraduate Research Office Summer Research Fellowship in 2016.
Currently, Ivan is conducting research with the support of a Pelotonia Fellowship provided by Pelotonia, an Ohio State fund-raising initiative which has raised more than $130 million to fund cancer research at Ohio State.
For his Undergraduate Research Office Summer Research Fellowship, Ivan worked in the laboratory of Professor and CBE Department Chair Andre Palmer, where researchers are working to perfect hemoglobin-based oxygen carriers (HBOCs) with applications in transfusion medicine and tissue engineering. HBOCs (hemoglobin-based oxygen carriers) are a class of RBC substitute that use the natural oxygen-carrying protein molecule hemoglobin (Hb) to store and transport oxygen, and could potentially be used as a short-term RBC replacement to greatly improve the care of accident victims, wounded soldiers, and RBC transfusion recipients, especially when blood is in short supply.
While real whole blood serves many different functions, artificial RBCs are designed for the sole purpose of transporting oxygen and carbon dioxide throughout the body.
HBOCs can be transfused into any patient with any blood type and, unlike real whole blood, can be safely stored longterm without refrigeration. However, researchers have not yet solved the potential problem of heme toxicity resulting when hemoglobin breaks down, leading to complications.
Ivan is interested in pursuing a career in research and development or bio-pharmaceutical process development/managing.